About Angelman syndrome due to maternal 15q11q13 deletion
Angelman syndrome due to maternal 15q11q13 deletion is a rare disease catalogued by Orphanet (ORPHA:98794). It is associated with the UBE3A, OCA2 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Angelman syndrome due to maternal 15q11q13 deletion trials.
Search ClinicalTrials.gov for "Angelman syndrome due to maternal 15q11q13 deletion" or filter by Orphanet code ORPHA:98794 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Angelman syndrome due to maternal 15q11q13 deletion trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Angelman syndrome due to maternal 15q11q13 deletion. Updated daily.